The purification of viral vectors and vaccines is a critical step in biopharmaceutical production. Affinity purifications, especially in the realm of affinity membrane applications, have become more effective tools for the purification of viruses and virus-like particles (VLPs) in recent years, significantly improving both the efficiency and the purity of these bioproducts. This article explores the complex field of purifications for viral vectors and vaccines, highlighting the importance of affinity purifications and the crucial role affinity membranes play for optimizing these critical processes.
Fig 1. Typical process for the purification of cell culture-derived biological nanoplexes, such as viruses. (Lothert K, Wolff MW. 2023)
Viral Vector and Vaccine Purifications
Viral vectors serve as intricately engineered vehicles, purposefully designed to deliver therapeutic genes to their designated cellular destinations, thereby assuming a pivotal role in the field of gene therapy. Their ability to navigate the complex biological terrain, orchestrating precise genetic modifications, underscores their profound significance.
Within the domain of bioproducts, both viral vectors and vaccines undergo a meticulous purification process, featuring stages such as filtration, chromatography, and precipitation techniques. Among these, affinity purification, a chromatographic method, emerges as a highly effective means of purifying viruses and virus-like particles. This method hinges on the specific binding between a ligand immobilized on a solid support, known as the affinity resin, and the target molecule, either a virus or a virus-like particle. The result is a purification process characterized by its selectivity and efficiency.
Affinity Purifications for Viruses and VLPs
Affinity purifications offer several advantages for the purification of viruses and VLPs. These advantages stem from the specific interactions between the ligand and the target molecule. Some of the most commonly used affinity ligands for viral vector and vaccine purification include heparin, Protein A, Protein G, and monoclonal antibodies.
Heparin, recognized for its capacity to bind with viral envelope glycoproteins, demonstrates its efficacy in capturing viral particles and safeguarding the integrity of target molecules, rendering it a fundamental component of efficient purification processes.
Protein A and Protein G, revered for their specificity in the purification of antibody-based products, play a pivotal role in the purification of VLPs that incorporate antibodies as antigens. The discerning nature of their binding ensures robust yields of VLPs adorned with antibodies.
Monoclonal antibodies, precisely engineered to target and bind to specific viral antigens, are immobilized onto an affinity resin to facilitate the purification of viruses and VLPs. This approach ensures a highly specific and efficient purification process.
Affinity Membrane Applications for Virus and VLP Purification
While affinity chromatography has been the traditional choice for virus and VLP purification, the emergence of affinity membrane applications has opened up new possibilities in terms of efficiency and scalability. Affinity membranes, solid supports incorporating immobilized affinity ligands, bear a resemblance to their chromatographic counterparts, namely the affinity resins. However, they introduce a subtle yet profound shift in the purification landscape. Affinity membranes offer the prospect of continuous and streamlined processing, an enticing prospect, particularly in the context of large-scale viral vector and vaccine production. This transition from traditional batch chromatography to continuous processing holds the promise of significantly increased productivity, reduction in downtime, and a more cost-effective approach.
Furthermorem, affinity membranes have a smaller footprint compared to traditional chromatography systems, making them suitable for facilities with limited space. This factor can be especially beneficial in the production of viral vectors and vaccines, which often require multiple purification steps.
Scalability is another distinguishing feature. Affinity membranes are easily scalable, allowing manufacturers to adapt their purification processes to varying production volumes. Whether you are producing small batches for clinical trials or large quantities for commercial use, affinity membranes can be adjusted accordingly.
Reference
-
Lothert K, Wolff MW. Affinity and Pseudo-Affinity Membrane Chromatography for Viral Vector and Vaccine Purifications: A Review. Membranes (Basel). 2023; 13(9):770.
.
